Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Shockwave Newsletter

MedAxiom partners with Shockwave Medical to support ‘game-changing’ IVL technology

Shockwave Medical, now a part of Johnson & Johnson MedTech, continues to gain momentum among U.S. cardiologists. According to one MedAxiom executive, IVL "brings an important dimension to cardiovascular care for patients with calcified coronary and peripheral arterial disease."

Advanced device-based therapies are associated with significant benefits for heart failure patients and should be used alongside traditional pharmaceutical treatments, according to a new scientific statement from the Heart Failure Society of America (HFSA). The statement, published in full in the Journal of Cardiac Failure, examines a number of new-look medical devices that have emerged in recent years as additional ways to treat heart failure.

Cardiologists make case for increasing use of device-based therapies for heart failure

Device-based therapies can provide considerable value for heart failure patients when used alongside traditional pharmaceutical treatments. A new HFSA scientific statement outlines the benefits of these devices, urging care teams to implement them into daily practice. 

Thumbnail

Women less likely to survive heart surgery complications than men

"We are failing to rescue women after high-risk surgery," one researcher said after reviewing years of Medicare data. 

cardiologist salary and compensation data

Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Contego Medical, a North Carolina-based medical device company, has received U.S. Food and Drug Administration (FDA) approval for its new all-in-one carotid stenting offering, the Neuroguard IEP System

FDA gives green light to 3-in-1 carotid stent system designed to limit strokes

The newly approved system includes a stent, dilation balloon and integrated embolic protection filter. After CMS expanded Medicare coverage for carotid artery stenting in 2023, the procedures are expected to grow more and more common as time goes on. 

Massachusetts Institute of Technology won a $50,000 award to help commercialize its 3D printed, polymeric auxetic stent to treat pediatric aortic coarctation. It is bioresorbable so the patient can continue to grow without the need for as many reinterventions.

Pediatric cardiology device competition introduces world to new technologies

Most cardiac devices do not fit young children, making it especially important for growth in pediatric cardiology to continue. The FDA helped fund a contest aimed at identifying new devices that show a ton of potential. 

Vanderbilt University Medical Center sign

Endoscopies at Vanderbilt exposed patients to HIV, hepatitis C

The exact number of patients potentially infected was not released. However, the botched procedures date back some six months. 

https://www.dynocardia.care/

NIH awards commercialization grant for wrist-worn continuous ICU-grade blood pressure monitor

Dynocardia has now received nearly $5.1 million in funding from the NHLBI to help speed commercializing its wrist-worn monitor to avoid the need for invasive catheter BP monitoring.